Cargando…

Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases

Detalles Bibliográficos
Autores principales:	Bacon, Bruce R, Adams, Paul C, Kowdley, Kris V, Powell, Lawrie W, Tavill, Anthony S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Subscription Services, Inc., A Wiley Company 2011
Materias:	AASLD Practice Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149125/ https://www.ncbi.nlm.nih.gov/pubmed/21452290 http://dx.doi.org/10.1002/hep.24330

Ejemplares similares

An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
por: Ghany, Marc G, et al.
Publicado: (2011)

Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver
por: Crawford, Darrell H. G., et al.
Publicado: (2023)

Management of hepatocellular carcinoma: An update
por: Bruix, Jordi, et al.
Publicado: (2011)

Introduction to the Revised American Association for the Study of Liver Diseases Position Paper on Acute Liver Failure 2011
por: Lee, William M, et al.
Publicado: (2012)

Mo1330: THE IMPACT OF COVID-19 ON ALCOHOLIC LIVER DISEASES IN A PREDOMINANTLY AFRICAN AMERICAN AND HISPANIC COMMUNITY
por: Sun, Haozhe, et al.
Publicado: (2022)

Guidelines for the diagnosis and treatment of follicular lymphoma in China
Publicado: (2013)

Su1373: UTILIZATION OF DRUG OVERDOSE DONORS FOR LIVER TRANSPLANTATION DURING COVID-19 PANDEMIC
por: Lymberopoulos, Peter, et al.
Publicado: (2022)

Liver Transplant Society of India Guidelines for Liver Transplant During COVID-19 times
por: Gupta, Subash, et al.
Publicado: (2022)

Tu1267: TELEMEDICINE DURING COVID-19 PANDEMIC IS AN ACCEPTABLE MODALITY FOR LIVER CARE DELIVERY IN VULNERABLE POPULATIONS WITH FATTY LIVER DISEASE
por: Khalili, Mandana, et al.
Publicado: (2022)

The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
por: Fouad, Yasser, et al.
Publicado: (2022)

784: THE IMPACT OF THE CORONAVIRUS PANDEMIC AND GOVERNMENT LOCKDOWNS ON LIVER DISEASE HOSPITALIZATIONS, INPATIENT MORTALITY, AND LIVER TRANSPLANT SURGERY IN CALIFORNIA: A POPULATION-LEVEL ANALYSIS
por: Adekunle, Ayooluwatomiwa D., et al.
Publicado: (2022)

Tu1260: IMPACT OF COVID-19 ON PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS
por: Moga, Tudor V., et al.
Publicado: (2022)

10 IMPACT OF CHRONIC LIVER DISEASE ON THE COVID-19 HOSPITAL ADMITTED PATIENTS
por: Amjad, Waseem, et al.
Publicado: (2021)

Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
por: Kalligeros, Markos, et al.
Publicado: (2022)

Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma
por: Alqahtani, Saleh A., et al.
Publicado: (2020)

EP1195: COVID-19 INFECTION AND BREAKTHROUGH INFECTION IN POST LIVER TRANSPLANT PATIENTS
por: Moein, Hamid-Reza, et al.
Publicado: (2022)

Tu1270: SEROLOGICAL RESPONSE TO SARS-COV-2 VACCINES IN LIVER TRANSPLANT PATIENTS
por: Toapanta-Yanchapaxi, Liz, et al.
Publicado: (2022)

Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association
por: Levenhagen, Kimberly, et al.
Publicado: (2017)

Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults
por: Aschner, Pablo M, et al.
Publicado: (2016)

Su324 THE IMPACT OF THE COVID-19 PANDEMIC ON LIVER BIOMARKERS AND QUALITY OF LIFE IN PATIENTS WITH NAFLD
por: Clarke, Lindsay M., et al.
Publicado: (2021)

EP1192: LIVER TEST ABNORMALITIES IN COVID-19 PATIENTS MAY NOT BE RELATED TO CYTOKINE STORM
por: Piskorz, Maria, et al.
Publicado: (2022)

Tu1266: VARIABLE IMPACT OF COVID-19 PANDEMIC ON HOSPITALIZATION FOR ALCOHOL-ASSOCIATED LIVER DISEASE.
por: Lee, Tai-Ping, et al.
Publicado: (2022)

Mo1336: PREVALENCE AND MORTALITY OF ALCOHOL-RELATED LIVER DISEASES DURING COVID-19 PANDEMIC
por: Yeo, Yee Hui, et al.
Publicado: (2022)

Su327 DIAGNOSIS AND CHARACTERISTICS OF IMMUNE CHECKPOINT INHIBITOR-MEDIATED CHOLANGIOPATHY: A CASE SERIES
por: Eyada, Mostafa, et al.
Publicado: (2021)

8 PREDICTORS OF OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
por: Sandhu, Sunny, et al.
Publicado: (2021)

Su323 THE PATTERNS OF LIVER INJURY IN COVID-19 POSITIVE PREGNANT FEMALES: A CASE SERIES
por: Raju, Sneha, et al.
Publicado: (2021)

Su325 HEPATIC STEATOSIS MAY LEAD TO WORSE OUTCOMES IN PATIENTS WITH LIVER INJURY AND COVID-19
por: Shaikh, Danial H., et al.
Publicado: (2021)

EP1194: THE PROGNOSTIC IMPLICATIONS OF LIVER FUNCTION TEST ABNORMALITIES IN PATIENTS ADMITTED TO HOSPITAL WITH COVID-19
por: Cohen, Jason, et al.
Publicado: (2022)

435 INCIDENCE AND MORTALITY OF COVID-19 IN POST-LIVER TRANSPLANT PATIENTS IN A LARGE INTEGRATED HEALTHCARE SYSTEM
por: Tien, Andy, et al.
Publicado: (2021)

7 A RETROSPECTIVE ANALYSIS OF COVID-19 INFECTED PATIENTS WITH ACUTE LIVER FAILURE IN A SAFETY NET HOSPITAL
por: Pellegrini, James R., et al.
Publicado: (2021)

Su317 CORONAVIRUS DISEASE 2019 AND LIVER INJURY: A RETROSPECTIVE ANALYSIS OF HOSPITALIZED PATIENTS IN NEW YORK CITY
por: Bender, Joshua M., et al.
Publicado: (2021)

Tu1256: METFORMIN USE IS ASSOCIATED WITH LESS FREQUENT SEVERE LIVER INJURY UPON HOSPITAL ADMISSIN WITH COVID-19
por: Kuntzen, Christian, et al.
Publicado: (2022)

Clinical Guidelines for Diagnosis and Management of Juvenile Polyposis Syndrome in Children and Adults―Secondary Publication
por: Matsumoto, Takayuki, et al.
Publicado: (2023)

Tu1268: LONGITUDINAL ASSESSMENT OF SEROLOGICAL RESPONSE AFTER THREE DOSES OF SARS-COV-2 MRNA VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Gandle, Cassandra, et al.
Publicado: (2022)

9 ELEVATED LIVER ENZYMES PORTENDS A HIGHER RATE OF COMPLICATIONS AND DEATH IN ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)
por: Currier, Emily E., et al.
Publicado: (2021)

Su318 PATTERNS OF LIVER TRANSPLANTATION EVALUATIONS FOR HOSPITALIZED ADULTS WITH ACUTE ALCOHOLIC HEPATITIS DURING COVID-19: A SINGLE CENTER STUDY
por: Bangaru, Saroja, et al.
Publicado: (2021)

783: INCIDENCE AND OUTCOMES OF COVID-19 IN POST-LIVER TRANSPLANT RECIPIENTS AFTER COVID-19 VACCINATION IN A LARGE INTEGRATED HEALTHCARE SYSTEM
por: Tien, Andy, et al.
Publicado: (2022)

EP1193: A NOVEL PROGNOSTIC MODEL INCLUDING LIVER FUNCTION PARAMETERS ACCURATELY PREDICTS 30-DAY MORTALITY IN PATIENTS ADMITTED WITH COVID-19
por: Lee, David U., et al.
Publicado: (2022)

11 TRENDS IN ALCOHOL RELATED LIVER DISEASE DURING THE SARS-COV 2 PANDEMIC: REAL-TIME ANALYSIS OF SYSTEMWIDE DATA TRENDS USING EPIC SLICERDICER™.
por: Roark, Travis, et al.
Publicado: (2021)

Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d5salq17sp74dbjhnjjoifei7j